CVE-2026-18849: IBM OPENBMC · Path Traversal
Affects IBM OPENBMCSource CVE Database V5
Not known to be exploited · CVSS 6.8 Medium.
Data as of 18 Nov 2026, 20:25 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 31% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 19 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 18 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMOPENBMC | Affected
| Fixed in– |
AI-suggested
Until an official fix is available, restrict administrator-level access to the BMC to trusted personnel only and monitor for any unusual activity related to firmware updates.
Description
IBM OpenBMC versions FW1060.00 through FW1060.80 contain a path traversal vulnerability in the BMC firmware update process. This flaw allows an attacker with authenticated administrator-level access to execute arbitrary code, potentially impacting confidentiality, integrity, and availability of the system. The vulnerability is identified as CWE-22 and has a CVSS 3.1 base score of 6.8, indicating a medium severity level.